

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.89088811 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.89088811 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.36523015 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.36523015 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.30420660 |
| 6 | endothelium development (GO:0003158) | 4.16009106 |
| 7 | tryptophan catabolic process (GO:0006569) | 3.88542297 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 3.88542297 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 3.88542297 |
| 10 | tryptophan metabolic process (GO:0006568) | 3.83888196 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.76740974 |
| 12 | protein carboxylation (GO:0018214) | 3.71294903 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.71294903 |
| 14 | complement activation, alternative pathway (GO:0006957) | 3.65306435 |
| 15 | neural tube formation (GO:0001841) | 3.60653984 |
| 16 | phospholipid efflux (GO:0033700) | 3.58185858 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 3.56823014 |
| 18 | phospholipid homeostasis (GO:0055091) | 3.53520821 |
| 19 | bile acid biosynthetic process (GO:0006699) | 3.47022480 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 3.42420302 |
| 21 | thrombin receptor signaling pathway (GO:0070493) | 3.41300678 |
| 22 | negative regulation of lipase activity (GO:0060192) | 3.39458480 |
| 23 | cholesterol efflux (GO:0033344) | 3.39162991 |
| 24 | fatty acid elongation (GO:0030497) | 3.38790890 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.38149588 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.38149588 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.38149588 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.38149588 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.38149588 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.38149588 |
| 31 | regulation of protein activation cascade (GO:2000257) | 3.37078319 |
| 32 | kynurenine metabolic process (GO:0070189) | 3.35769335 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.34165557 |
| 34 | reverse cholesterol transport (GO:0043691) | 3.34096598 |
| 35 | microglial cell activation (GO:0001774) | 3.33277191 |
| 36 | urea cycle (GO:0000050) | 3.31783528 |
| 37 | urea metabolic process (GO:0019627) | 3.31783528 |
| 38 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.31278606 |
| 39 | negative regulation of fibrinolysis (GO:0051918) | 3.30846668 |
| 40 | bile acid metabolic process (GO:0008206) | 3.27903854 |
| 41 | glyoxylate metabolic process (GO:0046487) | 3.25147145 |
| 42 | rhodopsin mediated signaling pathway (GO:0016056) | 3.23530329 |
| 43 | negative regulation of protein localization to cell surface (GO:2000009) | 3.20273268 |
| 44 | plasma lipoprotein particle clearance (GO:0034381) | 3.20017793 |
| 45 | regulation of complement activation (GO:0030449) | 3.19516118 |
| 46 | regulation of fibrinolysis (GO:0051917) | 3.15943012 |
| 47 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.11507186 |
| 48 | regulation of sarcomere organization (GO:0060297) | 3.08986272 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 3.07970133 |
| 50 | bile acid and bile salt transport (GO:0015721) | 3.06194236 |
| 51 | plasma lipoprotein particle assembly (GO:0034377) | 3.05263392 |
| 52 | tyrosine metabolic process (GO:0006570) | 3.04948447 |
| 53 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.04712903 |
| 54 | nitrogen cycle metabolic process (GO:0071941) | 3.00398362 |
| 55 | indolalkylamine metabolic process (GO:0006586) | 2.99173570 |
| 56 | aromatic amino acid family metabolic process (GO:0009072) | 2.93905889 |
| 57 | cellular biogenic amine catabolic process (GO:0042402) | 2.92378967 |
| 58 | amine catabolic process (GO:0009310) | 2.92378967 |
| 59 | photoreceptor cell maintenance (GO:0045494) | 2.89908224 |
| 60 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.89762162 |
| 61 | fucose catabolic process (GO:0019317) | 2.88264640 |
| 62 | L-fucose metabolic process (GO:0042354) | 2.88264640 |
| 63 | L-fucose catabolic process (GO:0042355) | 2.88264640 |
| 64 | protein-lipid complex assembly (GO:0065005) | 2.88235356 |
| 65 | detection of light stimulus involved in visual perception (GO:0050908) | 2.84989496 |
| 66 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.84989496 |
| 67 | positive regulation of vasculogenesis (GO:2001214) | 2.83723996 |
| 68 | regulation of triglyceride catabolic process (GO:0010896) | 2.82505700 |
| 69 | triglyceride homeostasis (GO:0070328) | 2.82053567 |
| 70 | acylglycerol homeostasis (GO:0055090) | 2.82053567 |
| 71 | limb bud formation (GO:0060174) | 2.80486530 |
| 72 | very long-chain fatty acid metabolic process (GO:0000038) | 2.78232557 |
| 73 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.77543882 |
| 74 | platelet dense granule organization (GO:0060155) | 2.77446181 |
| 75 | homocysteine metabolic process (GO:0050667) | 2.76753920 |
| 76 | regulation of pigment cell differentiation (GO:0050932) | 2.74428855 |
| 77 | plasma lipoprotein particle remodeling (GO:0034369) | 2.74304962 |
| 78 | protein-lipid complex remodeling (GO:0034368) | 2.74304962 |
| 79 | macromolecular complex remodeling (GO:0034367) | 2.74304962 |
| 80 | interkinetic nuclear migration (GO:0022027) | 2.72945816 |
| 81 | cysteine metabolic process (GO:0006534) | 2.72712198 |
| 82 | cellular glucuronidation (GO:0052695) | 2.71715157 |
| 83 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.70768431 |
| 84 | negative regulation of cholesterol transport (GO:0032375) | 2.70233321 |
| 85 | negative regulation of sterol transport (GO:0032372) | 2.70233321 |
| 86 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.67084308 |
| 87 | macrophage activation involved in immune response (GO:0002281) | 2.66491202 |
| 88 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.66130882 |
| 89 | regulation of endothelial cell differentiation (GO:0045601) | 2.65167251 |
| 90 | complement activation (GO:0006956) | 2.65064979 |
| 91 | eye photoreceptor cell differentiation (GO:0001754) | 2.63981171 |
| 92 | photoreceptor cell differentiation (GO:0046530) | 2.63981171 |
| 93 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.63462374 |
| 94 | regulation of vasculogenesis (GO:2001212) | 2.63291752 |
| 95 | positive regulation of mast cell activation (GO:0033005) | 2.62374243 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.59945344 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.59945344 |
| 98 | cholesterol homeostasis (GO:0042632) | 2.59756687 |
| 99 | complement activation, classical pathway (GO:0006958) | 2.58877742 |
| 100 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.58069372 |
| 101 | phototransduction, visible light (GO:0007603) | 2.57354177 |
| 102 | regulation of bile acid biosynthetic process (GO:0070857) | 2.56683763 |
| 103 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.56076636 |
| 104 | fibrinolysis (GO:0042730) | 2.55605050 |
| 105 | linoleic acid metabolic process (GO:0043651) | 2.54499634 |
| 106 | sterol homeostasis (GO:0055092) | 2.54434384 |
| 107 | axon ensheathment in central nervous system (GO:0032291) | 2.54229756 |
| 108 | central nervous system myelination (GO:0022010) | 2.54229756 |
| 109 | protein activation cascade (GO:0072376) | 2.53548579 |
| 110 | positive regulation of developmental pigmentation (GO:0048087) | 2.53255540 |
| 111 | adaptation of signaling pathway (GO:0023058) | 2.52607423 |
| 112 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.52597401 |
| 113 | neutrophil activation involved in immune response (GO:0002283) | 2.52046672 |
| 114 | low-density lipoprotein particle remodeling (GO:0034374) | 2.51900867 |
| 115 | nerve growth factor signaling pathway (GO:0038180) | 2.51810919 |
| 116 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.51696536 |
| 117 | sulfur amino acid catabolic process (GO:0000098) | 2.50650740 |
| 118 | import into cell (GO:0098657) | 2.50538420 |
| 119 | glucuronate metabolic process (GO:0019585) | 2.50104540 |
| 120 | uronic acid metabolic process (GO:0006063) | 2.50104540 |
| 121 | phototransduction (GO:0007602) | 2.49369934 |
| 122 | auditory receptor cell differentiation (GO:0042491) | 2.49209417 |
| 123 | positive regulation of phosphatase activity (GO:0010922) | 2.48880646 |
| 124 | lipoprotein metabolic process (GO:0042157) | 2.48467962 |
| 125 | cyclic nucleotide catabolic process (GO:0009214) | 2.47904867 |
| 126 | response to lipoprotein particle (GO:0055094) | 2.47637136 |
| 127 | positive regulation of glycolytic process (GO:0045821) | 2.47526457 |
| 128 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.47192338 |
| 129 | plasma lipoprotein particle organization (GO:0071827) | 2.46768651 |
| 130 | DNA deamination (GO:0045006) | 2.44823583 |
| 131 | protein neddylation (GO:0045116) | 2.44294796 |
| 132 | angiogenesis involved in wound healing (GO:0060055) | 2.43116470 |
| 133 | heme transport (GO:0015886) | 2.42705059 |
| 134 | detection of visible light (GO:0009584) | 2.42503528 |
| 135 | retinal cone cell development (GO:0046549) | 2.42142737 |
| 136 | regulation of phospholipase A2 activity (GO:0032429) | 2.42003534 |
| 137 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.40078202 |
| 138 | regulation of germinal center formation (GO:0002634) | 2.40057697 |
| 139 | multicellular organism reproduction (GO:0032504) | 2.39298909 |
| 140 | cAMP catabolic process (GO:0006198) | 2.38887150 |
| 141 | endoderm formation (GO:0001706) | 2.38162537 |
| 142 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.34899397 |
| 143 | regulation of platelet activation (GO:0010543) | 2.32505138 |
| 144 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.31674827 |
| 145 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.31375261 |
| 146 | cardiac chamber formation (GO:0003207) | 2.30008868 |
| 147 | cellular extravasation (GO:0045123) | 2.29063773 |
| 148 | cellular response to ethanol (GO:0071361) | 2.24699130 |
| 149 | regulation of meiosis I (GO:0060631) | 2.23022456 |
| 150 | cardiac ventricle formation (GO:0003211) | 2.22981850 |
| 151 | establishment of protein localization to Golgi (GO:0072600) | 2.20658801 |
| 152 | regulation of neuron projection regeneration (GO:0070570) | 2.20292842 |
| 153 | regulation of axon regeneration (GO:0048679) | 2.20292842 |
| 154 | neutrophil activation (GO:0042119) | 2.19519551 |
| 155 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.17224369 |
| 156 | positive regulation of muscle hypertrophy (GO:0014742) | 2.17224369 |
| 157 | negative regulation of mast cell activation (GO:0033004) | 2.16633368 |
| 158 | protein K11-linked deubiquitination (GO:0035871) | 2.16544248 |
| 159 | somite development (GO:0061053) | 2.16123389 |
| 160 | behavioral response to nicotine (GO:0035095) | 2.14712164 |
| 161 | superoxide anion generation (GO:0042554) | 2.14305578 |
| 162 | glial cell proliferation (GO:0014009) | 2.14059030 |
| 163 | thyroid hormone generation (GO:0006590) | 2.13409834 |
| 164 | activated T cell proliferation (GO:0050798) | 2.12672963 |
| 165 | sphingoid metabolic process (GO:0046519) | 2.11452586 |
| 166 | keratinization (GO:0031424) | 2.11435548 |
| 167 | negative regulation of neurotransmitter transport (GO:0051589) | 2.10741294 |
| 168 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.09899110 |
| 169 | thyroid hormone metabolic process (GO:0042403) | 2.09876267 |
| 170 | glycosphingolipid biosynthetic process (GO:0006688) | 2.09046391 |
| 171 | piRNA metabolic process (GO:0034587) | 2.08790566 |
| 172 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.08716811 |
| 173 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.08352699 |
| 174 | positive regulation of protein homodimerization activity (GO:0090073) | 2.08113263 |
| 175 | positive regulation of steroid hormone secretion (GO:2000833) | 2.07440628 |
| 176 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.07027394 |
| 177 | positive regulation of mast cell degranulation (GO:0043306) | 2.07027394 |
| 178 | Rap protein signal transduction (GO:0032486) | 2.05708359 |
| 179 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.02910582 |
| 180 | negative regulation of platelet activation (GO:0010544) | 2.02709057 |
| 181 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.02708462 |
| 182 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.02664122 |
| 183 | regulation of mast cell activation (GO:0033003) | 2.02517684 |
| 184 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.02221576 |
| 185 | regulation of hippo signaling (GO:0035330) | 2.01303841 |
| 186 | dopamine transport (GO:0015872) | 2.00765601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.67750537 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.73124582 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.55908684 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.07931415 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.99043757 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.81628406 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.53781269 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.51318912 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.47850409 |
| 10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.39122132 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.34327101 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.24781082 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.12454617 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.11006519 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.08780519 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.87221085 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84452097 |
| 18 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.83632168 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82177353 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80813942 |
| 21 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.77536384 |
| 22 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77083641 |
| 23 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.73198601 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.70244355 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.69534299 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.68515267 |
| 27 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.64974747 |
| 28 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.64872345 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.64487293 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.62951642 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.62039167 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61604674 |
| 33 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.61279231 |
| 34 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.57130632 |
| 35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55499199 |
| 36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.55324296 |
| 37 | EWS_26573619_Chip-Seq_HEK293_Human | 1.53613115 |
| 38 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52160143 |
| 39 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.52160143 |
| 40 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.51662644 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50896882 |
| 42 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50755941 |
| 43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.49277999 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48747289 |
| 45 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.47882915 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47336462 |
| 47 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.46145145 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43847629 |
| 49 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.42781819 |
| 50 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.42514547 |
| 51 | TCF4_23295773_ChIP-Seq_U87_Human | 1.41230449 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40735694 |
| 53 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.40245250 |
| 54 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.37865599 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36269146 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36054917 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.33200575 |
| 58 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.31533527 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31037273 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30685165 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.30204702 |
| 62 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.29515514 |
| 63 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.29515514 |
| 64 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.28435593 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28127774 |
| 66 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25674629 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25218174 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24676347 |
| 69 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.23934759 |
| 70 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23671837 |
| 71 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.23019491 |
| 72 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22521911 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21809138 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21466141 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21034464 |
| 76 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20746494 |
| 77 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20647747 |
| 78 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19138876 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.18262858 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18257468 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18050256 |
| 82 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17472212 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17354051 |
| 84 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16963409 |
| 85 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15577568 |
| 86 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14662620 |
| 87 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13658077 |
| 88 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13658077 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13448138 |
| 90 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13128854 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12417127 |
| 92 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11879886 |
| 93 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11479239 |
| 94 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.11334875 |
| 95 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11311961 |
| 96 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11193325 |
| 97 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.10917431 |
| 98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10890335 |
| 99 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.10511479 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08771227 |
| 101 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08536265 |
| 102 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.08014167 |
| 103 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07831128 |
| 104 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07665203 |
| 105 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05879568 |
| 106 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.04942078 |
| 107 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.03504807 |
| 108 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.03311548 |
| 109 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02329072 |
| 110 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02170594 |
| 111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01999439 |
| 112 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00580207 |
| 113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00185635 |
| 114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00185635 |
| 115 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.99155682 |
| 116 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.98775800 |
| 117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97339696 |
| 118 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97134452 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96897277 |
| 120 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95870809 |
| 121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93381574 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93124780 |
| 123 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92500265 |
| 124 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92218058 |
| 125 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.91018242 |
| 126 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90644916 |
| 127 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90358999 |
| 128 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.90347103 |
| 129 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88185462 |
| 130 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.86880752 |
| 131 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85361482 |
| 132 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84617836 |
| 133 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.84268285 |
| 134 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84215749 |
| 135 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.82855328 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82253536 |
| 137 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.81012580 |
| 138 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.80272958 |
| 139 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.79817488 |
| 140 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79021569 |
| 141 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.78573551 |
| 142 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.78017083 |
| 143 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78014749 |
| 144 | TP53_16413492_ChIP-PET_HCT116_Human | 0.77967697 |
| 145 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77964956 |
| 146 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77633999 |
| 147 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77300910 |
| 148 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.77023605 |
| 149 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.76754262 |
| 150 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75631311 |
| 151 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75097702 |
| 152 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.74893359 |
| 153 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74726504 |
| 154 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.74481161 |
| 155 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.74269967 |
| 156 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.73444881 |
| 157 | P300_19829295_ChIP-Seq_ESCs_Human | 0.72440894 |
| 158 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.72264558 |
| 159 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.70883081 |
| 160 | TBL1_22424771_ChIP-Seq_293T_Human | 0.70652224 |
| 161 | STAT3_23295773_ChIP-Seq_U87_Human | 0.70020637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.04862898 |
| 2 | MP0005360_urolithiasis | 4.46149053 |
| 3 | MP0003011_delayed_dark_adaptation | 4.31945594 |
| 4 | MP0005365_abnormal_bile_salt | 4.22096014 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.06653603 |
| 6 | MP0003252_abnormal_bile_duct | 3.45118108 |
| 7 | MP0009840_abnormal_foam_cell | 3.31188762 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.26657050 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 3.14616414 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 3.02774001 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.92544021 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.45274475 |
| 13 | MP0003690_abnormal_glial_cell | 2.40822601 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.24784460 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.24758661 |
| 16 | MP0008004_abnormal_stomach_pH | 2.20580936 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.16974663 |
| 18 | MP0003646_muscle_fatigue | 2.16694899 |
| 19 | MP0003828_pulmonary_edema | 2.11002695 |
| 20 | MP0004084_abnormal_cardiac_muscle | 2.07906066 |
| 21 | MP0005083_abnormal_biliary_tract | 2.07707585 |
| 22 | MP0005451_abnormal_body_composition | 1.99361058 |
| 23 | MP0010368_abnormal_lymphatic_system | 1.90155991 |
| 24 | MP0005253_abnormal_eye_physiology | 1.89653821 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.85015550 |
| 26 | MP0002254_reproductive_system_inflammat | 1.83415992 |
| 27 | MP0004215_abnormal_myocardial_fiber | 1.79139544 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.76944472 |
| 29 | MP0005084_abnormal_gallbladder_morpholo | 1.69049981 |
| 30 | MP0008775_abnormal_heart_ventricle | 1.60691598 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.59981446 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.59848170 |
| 33 | MP0005174_abnormal_tail_pigmentation | 1.59277704 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.54445921 |
| 35 | MP0000609_abnormal_liver_physiology | 1.54047204 |
| 36 | MP0006082_CNS_inflammation | 1.53615930 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.53564178 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.53488352 |
| 39 | MP0002118_abnormal_lipid_homeostasis | 1.52771383 |
| 40 | MP0005332_abnormal_amino_acid | 1.51825605 |
| 41 | MP0003303_peritoneal_inflammation | 1.50311484 |
| 42 | MP0003045_fibrosis | 1.50106950 |
| 43 | MP0000383_abnormal_hair_follicle | 1.48674122 |
| 44 | MP0003195_calcinosis | 1.48248635 |
| 45 | MP0002090_abnormal_vision | 1.47491374 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.45098262 |
| 47 | MP0001324_abnormal_eye_pigmentation | 1.44860424 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.44729637 |
| 49 | MP0005195_abnormal_posterior_eye | 1.44282911 |
| 50 | MP0008877_abnormal_DNA_methylation | 1.44185431 |
| 51 | MP0000604_amyloidosis | 1.44107510 |
| 52 | MP0000920_abnormal_myelination | 1.41542433 |
| 53 | MP0002653_abnormal_ependyma_morphology | 1.36390332 |
| 54 | MP0002928_abnormal_bile_duct | 1.34536194 |
| 55 | MP0001764_abnormal_homeostasis | 1.34424275 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.32753372 |
| 57 | MP0000230_abnormal_systemic_arterial | 1.30570647 |
| 58 | MP0008789_abnormal_olfactory_epithelium | 1.29826469 |
| 59 | MP0004043_abnormal_pH_regulation | 1.28061667 |
| 60 | MP0004484_altered_response_of | 1.27128728 |
| 61 | MP0005670_abnormal_white_adipose | 1.26576406 |
| 62 | MP0010678_abnormal_skin_adnexa | 1.25842992 |
| 63 | MP0001486_abnormal_startle_reflex | 1.25546719 |
| 64 | MP0002419_abnormal_innate_immunity | 1.21919939 |
| 65 | MP0006054_spinal_hemorrhage | 1.17367206 |
| 66 | MP0002102_abnormal_ear_morphology | 1.17238800 |
| 67 | MP0001968_abnormal_touch/_nociception | 1.17047606 |
| 68 | MP0003787_abnormal_imprinting | 1.16208347 |
| 69 | MP0009764_decreased_sensitivity_to | 1.14539003 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.13335532 |
| 71 | MP0002234_abnormal_pharynx_morphology | 1.12762563 |
| 72 | MP0008872_abnormal_physiological_respon | 1.09220095 |
| 73 | MP0009785_altered_susceptibility_to | 1.08908223 |
| 74 | MP0002229_neurodegeneration | 1.08398626 |
| 75 | MP0004381_abnormal_hair_follicle | 1.08228582 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 1.07209904 |
| 77 | MP0000372_irregular_coat_pigmentation | 1.07060784 |
| 78 | MP0002095_abnormal_skin_pigmentation | 1.07032717 |
| 79 | MP0005410_abnormal_fertilization | 1.05212599 |
| 80 | MP0002736_abnormal_nociception_after | 1.05022646 |
| 81 | MP0005391_vision/eye_phenotype | 1.04546153 |
| 82 | MP0001851_eye_inflammation | 1.04368963 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 1.02642651 |
| 84 | MP0005171_absent_coat_pigmentation | 1.02559041 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 1.01659681 |
| 86 | MP0004085_abnormal_heartbeat | 1.00629316 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00290583 |
| 88 | MP0005408_hypopigmentation | 1.00251323 |
| 89 | MP0003724_increased_susceptibility_to | 0.99821341 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.98939928 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.98379745 |
| 92 | MP0003868_abnormal_feces_composition | 0.97946421 |
| 93 | MP0009643_abnormal_urine_homeostasis | 0.97091753 |
| 94 | MP0003075_altered_response_to | 0.96679498 |
| 95 | MP0009697_abnormal_copulation | 0.96671180 |
| 96 | MP0008469_abnormal_protein_level | 0.96219431 |
| 97 | MP0000343_altered_response_to | 0.93889927 |
| 98 | MP0003436_decreased_susceptibility_to | 0.93865534 |
| 99 | MP0004036_abnormal_muscle_relaxation | 0.93510812 |
| 100 | MP0004142_abnormal_muscle_tone | 0.93391109 |
| 101 | MP0004782_abnormal_surfactant_physiolog | 0.92807885 |
| 102 | MP0001835_abnormal_antigen_presentation | 0.92280305 |
| 103 | MP0002272_abnormal_nervous_system | 0.91295178 |
| 104 | MP0005000_abnormal_immune_tolerance | 0.89900932 |
| 105 | MP0005595_abnormal_vascular_smooth | 0.89515810 |
| 106 | MP0002638_abnormal_pupillary_reflex | 0.88547006 |
| 107 | MP0002876_abnormal_thyroid_physiology | 0.87911977 |
| 108 | MP0006072_abnormal_retinal_apoptosis | 0.87518349 |
| 109 | MP0002168_other_aberrant_phenotype | 0.86744669 |
| 110 | MP0001879_abnormal_lymphatic_vessel | 0.86719284 |
| 111 | MP0004885_abnormal_endolymph | 0.86648032 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.84985453 |
| 113 | MP0000767_abnormal_smooth_muscle | 0.84357023 |
| 114 | MP0002723_abnormal_immune_serum | 0.84206750 |
| 115 | MP0004742_abnormal_vestibular_system | 0.83901978 |
| 116 | MP0001800_abnormal_humoral_immune | 0.83099470 |
| 117 | MP0009763_increased_sensitivity_to | 0.81082099 |
| 118 | MP0005394_taste/olfaction_phenotype | 0.80808205 |
| 119 | MP0005499_abnormal_olfactory_system | 0.80808205 |
| 120 | MP0004510_myositis | 0.80720664 |
| 121 | MP0003136_yellow_coat_color | 0.79906340 |
| 122 | MP0002733_abnormal_thermal_nociception | 0.79863676 |
| 123 | MP0005387_immune_system_phenotype | 0.79232767 |
| 124 | MP0001790_abnormal_immune_system | 0.79232767 |
| 125 | MP0002972_abnormal_cardiac_muscle | 0.78840380 |
| 126 | MP0005248_abnormal_Harderian_gland | 0.78699532 |
| 127 | MP0002098_abnormal_vibrissa_morphology | 0.78142174 |
| 128 | MP0005647_abnormal_sex_gland | 0.77947954 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.76914123 |
| 130 | MP0003453_abnormal_keratinocyte_physiol | 0.76489036 |
| 131 | MP0001915_intracranial_hemorrhage | 0.76035744 |
| 132 | MP0003634_abnormal_glial_cell | 0.75695532 |
| 133 | MP0001533_abnormal_skeleton_physiology | 0.74988424 |
| 134 | MP0005197_abnormal_uvea_morphology | 0.74375636 |
| 135 | MP0003633_abnormal_nervous_system | 0.73576141 |
| 136 | MP0000598_abnormal_liver_morphology | 0.73197988 |
| 137 | MP0002127_abnormal_cardiovascular_syste | 0.72945801 |
| 138 | MP0009745_abnormal_behavioral_response | 0.72939106 |
| 139 | MP0006276_abnormal_autonomic_nervous | 0.72722978 |
| 140 | MP0005397_hematopoietic_system_phenotyp | 0.70718766 |
| 141 | MP0001545_abnormal_hematopoietic_system | 0.70718766 |
| 142 | MP0001970_abnormal_pain_threshold | 0.69864785 |
| 143 | MP0001756_abnormal_urination | 0.69324851 |
| 144 | MP0010155_abnormal_intestine_physiology | 0.69074804 |
| 145 | MP0001986_abnormal_taste_sensitivity | 0.68925911 |
| 146 | MP0001984_abnormal_olfaction | 0.68486799 |
| 147 | MP0005025_abnormal_response_to | 0.65634580 |
| 148 | MP0004947_skin_inflammation | 0.64414095 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.64357745 |
| 150 | MP0002998_abnormal_bone_remodeling | 0.63460298 |
| 151 | MP0001845_abnormal_inflammatory_respons | 0.62759445 |
| 152 | MP0000249_abnormal_blood_vessel | 0.62082788 |
| 153 | MP0005334_abnormal_fat_pad | 0.61931892 |
| 154 | MP0000427_abnormal_hair_cycle | 0.61637892 |
| 155 | MP0005671_abnormal_response_to | 0.61294411 |
| 156 | MP0005166_decreased_susceptibility_to | 0.61261933 |
| 157 | MP0005409_darkened_coat_color | 0.59057365 |
| 158 | MP0009642_abnormal_blood_homeostasis | 0.58534364 |
| 159 | MP0002796_impaired_skin_barrier | 0.57396822 |
| 160 | MP0003632_abnormal_nervous_system | 0.56929088 |
| 161 | MP0005310_abnormal_salivary_gland | 0.55760651 |
| 162 | MP0002452_abnormal_antigen_presenting | 0.54097321 |
| 163 | MP0001853_heart_inflammation | 0.53734649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 5.69245535 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 5.68751240 |
| 3 | Complement deficiency (HP:0004431) | 5.52028560 |
| 4 | Pigmentary retinal degeneration (HP:0001146) | 5.18066720 |
| 5 | Glomerulonephritis (HP:0000099) | 4.75223540 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.56175510 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 4.55995203 |
| 8 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.09828314 |
| 9 | Chorioretinal atrophy (HP:0000533) | 4.00195557 |
| 10 | Abnormality of complement system (HP:0005339) | 3.99844603 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 3.96517820 |
| 12 | Xanthomatosis (HP:0000991) | 3.95972156 |
| 13 | Abolished electroretinogram (ERG) (HP:0000550) | 3.95192451 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.93197937 |
| 15 | Hyperventilation (HP:0002883) | 3.89818579 |
| 16 | Joint hemorrhage (HP:0005261) | 3.83282885 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 3.63469348 |
| 18 | Prolonged bleeding time (HP:0003010) | 3.55842728 |
| 19 | Fair hair (HP:0002286) | 3.44080111 |
| 20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.42646535 |
| 21 | Congenital, generalized hypertrichosis (HP:0004540) | 3.32256118 |
| 22 | Dyschromatopsia (HP:0007641) | 3.28181315 |
| 23 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.19754227 |
| 24 | Retinal atrophy (HP:0001105) | 3.19480342 |
| 25 | Central scotoma (HP:0000603) | 3.10099332 |
| 26 | Abnormality of the renal cortex (HP:0011035) | 3.09512018 |
| 27 | Pancreatic cysts (HP:0001737) | 3.05486026 |
| 28 | Generalized hypopigmentation of hair (HP:0011358) | 2.97723179 |
| 29 | Stomatitis (HP:0010280) | 2.95605416 |
| 30 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.93504253 |
| 31 | Abnormality of macular pigmentation (HP:0008002) | 2.92497252 |
| 32 | Widely spaced teeth (HP:0000687) | 2.92286519 |
| 33 | Decreased central vision (HP:0007663) | 2.89801504 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.87105985 |
| 35 | Progressive visual loss (HP:0000529) | 2.86990223 |
| 36 | Abnormality of the renal medulla (HP:0100957) | 2.85850830 |
| 37 | Absent speech (HP:0001344) | 2.84778986 |
| 38 | Axonal loss (HP:0003447) | 2.82680911 |
| 39 | Macular degeneration (HP:0000608) | 2.82635111 |
| 40 | Hypercholesterolemia (HP:0003124) | 2.81891336 |
| 41 | Nephritis (HP:0000123) | 2.80146874 |
| 42 | Thick nail (HP:0001805) | 2.78759130 |
| 43 | Myocardial infarction (HP:0001658) | 2.78353255 |
| 44 | Cone-rod dystrophy (HP:0000548) | 2.76345583 |
| 45 | Epidermoid cyst (HP:0200040) | 2.75765186 |
| 46 | Hypoalphalipoproteinemia (HP:0003233) | 2.75641539 |
| 47 | Thyroid-stimulating hormone excess (HP:0002925) | 2.74653969 |
| 48 | Neurofibrillary tangles (HP:0002185) | 2.71278893 |
| 49 | Esophageal varix (HP:0002040) | 2.70313280 |
| 50 | Hypobetalipoproteinemia (HP:0003563) | 2.70133192 |
| 51 | Abnormality of methionine metabolism (HP:0010901) | 2.66819944 |
| 52 | Amyloidosis (HP:0011034) | 2.66538544 |
| 53 | Portal hypertension (HP:0001409) | 2.60251706 |
| 54 | Fat malabsorption (HP:0002630) | 2.59578678 |
| 55 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.56544620 |
| 56 | Abnormality of secondary sexual hair (HP:0009888) | 2.56517492 |
| 57 | Abnormality of the axillary hair (HP:0100134) | 2.56517492 |
| 58 | True hermaphroditism (HP:0010459) | 2.55625996 |
| 59 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.54678412 |
| 60 | Scotoma (HP:0000575) | 2.54553951 |
| 61 | Hypolipoproteinemia (HP:0010981) | 2.52345413 |
| 62 | Vascular calcification (HP:0004934) | 2.51975684 |
| 63 | Stomach cancer (HP:0012126) | 2.50616881 |
| 64 | Pancreatic fibrosis (HP:0100732) | 2.50399007 |
| 65 | Decreased circulating renin level (HP:0003351) | 2.48901542 |
| 66 | Polydipsia (HP:0001959) | 2.48634913 |
| 67 | Abnormal drinking behavior (HP:0030082) | 2.48634913 |
| 68 | Nephronophthisis (HP:0000090) | 2.48523002 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.47530482 |
| 70 | Dysostosis multiplex (HP:0000943) | 2.46230115 |
| 71 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.45341796 |
| 72 | Conjugated hyperbilirubinemia (HP:0002908) | 2.44922811 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.42321181 |
| 74 | Abnormality of midbrain morphology (HP:0002418) | 2.41775616 |
| 75 | Molar tooth sign on MRI (HP:0002419) | 2.41775616 |
| 76 | Petechiae (HP:0000967) | 2.41226255 |
| 77 | Vitreoretinal degeneration (HP:0000655) | 2.41217930 |
| 78 | Congenital sensorineural hearing impairment (HP:0008527) | 2.39526540 |
| 79 | Attenuation of retinal blood vessels (HP:0007843) | 2.36725684 |
| 80 | Menorrhagia (HP:0000132) | 2.34525916 |
| 81 | Choroideremia (HP:0001139) | 2.34213855 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.32457002 |
| 83 | Gaze-evoked nystagmus (HP:0000640) | 2.31516931 |
| 84 | Epistaxis (HP:0000421) | 2.28341733 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.26599088 |
| 86 | Cupped ear (HP:0000378) | 2.26474311 |
| 87 | Abnormality of the hepatic vasculature (HP:0006707) | 2.25463562 |
| 88 | Gingival bleeding (HP:0000225) | 2.24961967 |
| 89 | Increased mean platelet volume (HP:0011877) | 2.24782748 |
| 90 | Pendular nystagmus (HP:0012043) | 2.24486660 |
| 91 | Renal cortical cysts (HP:0000803) | 2.23592736 |
| 92 | Blue irides (HP:0000635) | 2.21454839 |
| 93 | Peripheral demyelination (HP:0011096) | 2.19535084 |
| 94 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.17967471 |
| 95 | Recurrent bacterial skin infections (HP:0005406) | 2.17482465 |
| 96 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.16051458 |
| 97 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.16051458 |
| 98 | Abnormality of glycolipid metabolism (HP:0010969) | 2.16051458 |
| 99 | Hyperammonemia (HP:0001987) | 2.14848096 |
| 100 | Steatorrhea (HP:0002570) | 2.13243193 |
| 101 | Polyuria (HP:0000103) | 2.13213540 |
| 102 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12759985 |
| 103 | Cardiovascular calcification (HP:0011915) | 2.11682976 |
| 104 | Photophobia (HP:0000613) | 2.11225908 |
| 105 | Spontaneous hematomas (HP:0007420) | 2.10359408 |
| 106 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.09986782 |
| 107 | Thyroiditis (HP:0100646) | 2.08703904 |
| 108 | Purpura (HP:0000979) | 2.08078776 |
| 109 | Tubulointerstitial fibrosis (HP:0005576) | 2.05521294 |
| 110 | Tubular atrophy (HP:0000092) | 2.04283981 |
| 111 | Congenital hepatic fibrosis (HP:0002612) | 2.03938917 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03793523 |
| 113 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03793523 |
| 114 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03793523 |
| 115 | Hepatosplenomegaly (HP:0001433) | 2.02614189 |
| 116 | Optic neuritis (HP:0100653) | 2.02418807 |
| 117 | Retrobulbar optic neuritis (HP:0100654) | 2.02418807 |
| 118 | Adactyly (HP:0009776) | 2.02300150 |
| 119 | Type II lissencephaly (HP:0007260) | 2.01363790 |
| 120 | Abnormal platelet volume (HP:0011876) | 2.01152981 |
| 121 | Papillary thyroid carcinoma (HP:0002895) | 1.99452032 |
| 122 | Ketosis (HP:0001946) | 1.99293738 |
| 123 | Abnormality of the intrinsic pathway (HP:0010989) | 1.98749974 |
| 124 | Mucopolysacchariduria (HP:0008155) | 1.95743843 |
| 125 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95743843 |
| 126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93749663 |
| 127 | Hypoglycemic seizures (HP:0002173) | 1.92382362 |
| 128 | Hypokalemic alkalosis (HP:0001949) | 1.92127418 |
| 129 | Hepatocellular carcinoma (HP:0001402) | 1.92061524 |
| 130 | Tubulointerstitial abnormality (HP:0001969) | 1.91782608 |
| 131 | Mitral stenosis (HP:0001718) | 1.90920826 |
| 132 | Abnormality of glycine metabolism (HP:0010895) | 1.89811004 |
| 133 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.89811004 |
| 134 | Recurrent abscess formation (HP:0002722) | 1.85500709 |
| 135 | Hyperglycinemia (HP:0002154) | 1.84464777 |
| 136 | Type II diabetes mellitus (HP:0005978) | 1.84413331 |
| 137 | Febrile seizures (HP:0002373) | 1.83227447 |
| 138 | Submucous cleft hard palate (HP:0000176) | 1.81470522 |
| 139 | Hypoglycemic coma (HP:0001325) | 1.81212135 |
| 140 | Parakeratosis (HP:0001036) | 1.80805904 |
| 141 | Keratoconjunctivitis (HP:0001096) | 1.80584487 |
| 142 | Slow saccadic eye movements (HP:0000514) | 1.80192175 |
| 143 | Alkalosis (HP:0001948) | 1.79604299 |
| 144 | Chronic hepatic failure (HP:0100626) | 1.79371704 |
| 145 | Metabolic alkalosis (HP:0200114) | 1.78736313 |
| 146 | Hematochezia (HP:0002573) | 1.78468502 |
| 147 | Hyperglycinuria (HP:0003108) | 1.78280481 |
| 148 | Keratoconus (HP:0000563) | 1.78122208 |
| 149 | Increased corneal curvature (HP:0100692) | 1.78122208 |
| 150 | Pulmonary embolism (HP:0002204) | 1.78109346 |
| 151 | Genetic anticipation (HP:0003743) | 1.77167920 |
| 152 | Amelogenesis imperfecta (HP:0000705) | 1.76415157 |
| 153 | Inability to walk (HP:0002540) | 1.76079541 |
| 154 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76016038 |
| 155 | Subcapsular cataract (HP:0000523) | 1.75718809 |
| 156 | Conjunctival telangiectasia (HP:0000524) | 1.75165177 |
| 157 | Agitation (HP:0000713) | 1.74753585 |
| 158 | Alopecia of scalp (HP:0002293) | 1.74674549 |
| 159 | Hypophosphatemic rickets (HP:0004912) | 1.73827281 |
| 160 | Retinitis pigmentosa (HP:0000510) | 1.73671279 |
| 161 | Palmar hyperkeratosis (HP:0010765) | 1.72758434 |
| 162 | Broad-based gait (HP:0002136) | 1.72383668 |
| 163 | Absent/shortened dynein arms (HP:0200106) | 1.71816410 |
| 164 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.71816410 |
| 165 | 3-Methylglutaconic aciduria (HP:0003535) | 1.71119673 |
| 166 | Erythroderma (HP:0001019) | 1.70408522 |
| 167 | Pachygyria (HP:0001302) | 1.69631890 |
| 168 | Medial flaring of the eyebrow (HP:0010747) | 1.69272992 |
| 169 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.68460382 |
| 170 | Abnormality of the prostate (HP:0008775) | 1.68434004 |
| 171 | Short tibia (HP:0005736) | 1.67598547 |
| 172 | Drooling (HP:0002307) | 1.67457573 |
| 173 | Abnormality of renin-angiotensin system (HP:0000847) | 1.66196733 |
| 174 | Palmoplantar hyperkeratosis (HP:0000972) | 1.65042603 |
| 175 | Syncope (HP:0001279) | 1.64500527 |
| 176 | Keratoconjunctivitis sicca (HP:0001097) | 1.64352584 |
| 177 | Progressive cerebellar ataxia (HP:0002073) | 1.64153806 |
| 178 | Abnormal urine output (HP:0012590) | 1.62728416 |
| 179 | Tented upper lip vermilion (HP:0010804) | 1.61152226 |
| 180 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.60995179 |
| 181 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.60995179 |
| 182 | Curly hair (HP:0002212) | 1.60406089 |
| 183 | Volvulus (HP:0002580) | 1.58892561 |
| 184 | Disproportionate short-trunk short stature (HP:0003521) | 1.56213853 |
| 185 | Metaphyseal dysplasia (HP:0100255) | 1.55604504 |
| 186 | Autoimmune thrombocytopenia (HP:0001973) | 1.54056310 |
| 187 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.53455334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.86875089 |
| 2 | TGFBR2 | 3.72992810 |
| 3 | TAOK3 | 2.91576460 |
| 4 | MAP4K2 | 2.73896952 |
| 5 | GRK1 | 2.63303624 |
| 6 | BMPR1B | 2.49201188 |
| 7 | INSRR | 2.45895518 |
| 8 | EPHB1 | 2.43533323 |
| 9 | STK39 | 2.42525385 |
| 10 | MAPK15 | 2.25302827 |
| 11 | ADRBK2 | 2.14986377 |
| 12 | CAMK1D | 2.14831385 |
| 13 | NUAK1 | 2.06542299 |
| 14 | MAP3K14 | 2.05080845 |
| 15 | CAMK1G | 2.05025588 |
| 16 | ACVR1B | 1.98768204 |
| 17 | IRAK3 | 1.96245507 |
| 18 | TYK2 | 1.87265976 |
| 19 | CASK | 1.86017326 |
| 20 | STK38L | 1.71476192 |
| 21 | FGFR4 | 1.69194813 |
| 22 | PKN1 | 1.58636784 |
| 23 | PINK1 | 1.56856511 |
| 24 | MAPK13 | 1.53988855 |
| 25 | TIE1 | 1.53263239 |
| 26 | CSF1R | 1.53211274 |
| 27 | MET | 1.51335798 |
| 28 | TEC | 1.50483136 |
| 29 | TGFBR1 | 1.49847586 |
| 30 | SIK1 | 1.49066191 |
| 31 | WNK3 | 1.45605864 |
| 32 | JAK1 | 1.44769169 |
| 33 | OXSR1 | 1.43399124 |
| 34 | GRK7 | 1.42166864 |
| 35 | MST4 | 1.42154242 |
| 36 | IRAK2 | 1.38560782 |
| 37 | FGFR2 | 1.38541526 |
| 38 | SGK494 | 1.34401767 |
| 39 | SGK223 | 1.34401767 |
| 40 | NEK6 | 1.32137669 |
| 41 | MAPK7 | 1.30382238 |
| 42 | PTK6 | 1.25030919 |
| 43 | ERN1 | 1.23385701 |
| 44 | BLK | 1.22657920 |
| 45 | TXK | 1.21443504 |
| 46 | PTK2B | 1.19079601 |
| 47 | ITK | 1.18817294 |
| 48 | CLK1 | 1.18786605 |
| 49 | DAPK2 | 1.18085356 |
| 50 | MAP3K4 | 1.15005261 |
| 51 | PAK3 | 1.14913603 |
| 52 | TBK1 | 1.14131527 |
| 53 | LATS1 | 1.12701791 |
| 54 | IKBKE | 1.09087558 |
| 55 | TRIM28 | 1.07433563 |
| 56 | ICK | 1.06789436 |
| 57 | ERBB2 | 1.06632487 |
| 58 | SGK2 | 1.06052743 |
| 59 | PRPF4B | 1.01875822 |
| 60 | EPHA3 | 1.01652434 |
| 61 | MARK1 | 1.00329642 |
| 62 | NEK9 | 0.98778044 |
| 63 | SGK3 | 0.98211039 |
| 64 | IRAK4 | 0.96936281 |
| 65 | PBK | 0.94156058 |
| 66 | MAP3K13 | 0.93692374 |
| 67 | WNK4 | 0.92049345 |
| 68 | PRKAA2 | 0.91571190 |
| 69 | GSK3A | 0.87710325 |
| 70 | FGR | 0.87496548 |
| 71 | IRAK1 | 0.86155751 |
| 72 | CAMKK2 | 0.83999113 |
| 73 | CSK | 0.83245370 |
| 74 | OBSCN | 0.82797048 |
| 75 | MAPKAPK3 | 0.80641340 |
| 76 | ERBB3 | 0.80618769 |
| 77 | CSNK1A1L | 0.79557777 |
| 78 | NTRK2 | 0.77598136 |
| 79 | PRKCE | 0.77374562 |
| 80 | WNK1 | 0.77067982 |
| 81 | BTK | 0.76060871 |
| 82 | KDR | 0.76031211 |
| 83 | JAK2 | 0.75925835 |
| 84 | MAPK12 | 0.75692878 |
| 85 | SYK | 0.75445753 |
| 86 | BRSK2 | 0.74485478 |
| 87 | BCR | 0.73946006 |
| 88 | EPHB2 | 0.73924974 |
| 89 | PIK3CG | 0.72817400 |
| 90 | MAP2K7 | 0.72368503 |
| 91 | IKBKB | 0.71683161 |
| 92 | PLK2 | 0.69949915 |
| 93 | TRPM7 | 0.69830489 |
| 94 | NLK | 0.68446445 |
| 95 | CCNB1 | 0.66807105 |
| 96 | CHUK | 0.66426473 |
| 97 | PDGFRB | 0.65971740 |
| 98 | STK3 | 0.64666748 |
| 99 | ADRBK1 | 0.64546685 |
| 100 | PIK3CA | 0.64028671 |
| 101 | CSNK1G2 | 0.63866864 |
| 102 | YES1 | 0.63152503 |
| 103 | BCKDK | 0.62982669 |
| 104 | TNK2 | 0.62616963 |
| 105 | RIPK4 | 0.62471084 |
| 106 | ZAP70 | 0.62425046 |
| 107 | IGF1R | 0.62403461 |
| 108 | MAP2K6 | 0.62183364 |
| 109 | LYN | 0.60593603 |
| 110 | MARK3 | 0.59154185 |
| 111 | EGFR | 0.56895458 |
| 112 | PRKCQ | 0.56694033 |
| 113 | ZAK | 0.56574366 |
| 114 | LMTK2 | 0.55516348 |
| 115 | CDK6 | 0.54668567 |
| 116 | MAP3K5 | 0.53581817 |
| 117 | HCK | 0.53243108 |
| 118 | CSNK1G3 | 0.52399922 |
| 119 | MAP3K3 | 0.51402341 |
| 120 | PRKD1 | 0.50981607 |
| 121 | CDK12 | 0.50393608 |
| 122 | CSNK1G1 | 0.49944727 |
| 123 | EPHA4 | 0.49518643 |
| 124 | RIPK1 | 0.49436676 |
| 125 | PDPK1 | 0.49135671 |
| 126 | KIT | 0.48880081 |
| 127 | MAP2K2 | 0.48235014 |
| 128 | PDK2 | 0.48189399 |
| 129 | STK24 | 0.48060353 |
| 130 | STK10 | 0.46854698 |
| 131 | CDK3 | 0.46622565 |
| 132 | PRKG1 | 0.45694028 |
| 133 | PRKCZ | 0.45184745 |
| 134 | LCK | 0.45105788 |
| 135 | FGFR3 | 0.45066831 |
| 136 | MAP3K7 | 0.44900662 |
| 137 | FES | 0.44865151 |
| 138 | PTK2 | 0.44049260 |
| 139 | ABL1 | 0.43464107 |
| 140 | FER | 0.43001410 |
| 141 | DMPK | 0.42069504 |
| 142 | TNIK | 0.41921506 |
| 143 | CAMK4 | 0.41435120 |
| 144 | CAMK2A | 0.41230449 |
| 145 | AKT3 | 0.40650718 |
| 146 | MAP3K10 | 0.39961834 |
| 147 | MAPKAPK5 | 0.35605997 |
| 148 | FLT3 | 0.34798095 |
| 149 | PRKACA | 0.34404896 |
| 150 | MAP3K6 | 0.33850263 |
| 151 | MYLK | 0.32494584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 3.96507674 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.30653166 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.28245072 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.91651604 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.91648492 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.37817729 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.30368426 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.08508245 |
| 9 | ABC transporters_Homo sapiens_hsa02010 | 1.99559047 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98796721 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.97401570 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.94054234 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93066171 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92343856 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89232360 |
| 16 | Platelet activation_Homo sapiens_hsa04611 | 1.88874175 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.85093287 |
| 18 | Retinol metabolism_Homo sapiens_hsa00830 | 1.81868696 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.79982849 |
| 20 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.64184022 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.62730230 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.61708822 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.60597751 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60557449 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58294501 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.55415625 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.54145151 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53343718 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49740977 |
| 30 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.47791249 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47169585 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46248345 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.46131141 |
| 34 | Circadian rhythm_Homo sapiens_hsa04710 | 1.46050389 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.41997673 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41359110 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41301235 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38518776 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.38320052 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.29441065 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27732217 |
| 42 | Morphine addiction_Homo sapiens_hsa05032 | 1.27358302 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26523185 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.25085445 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.24118540 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.22237369 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 1.20254011 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17857257 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.15650775 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14876685 |
| 51 | Renin secretion_Homo sapiens_hsa04924 | 1.14864816 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14212057 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.12859181 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.12540273 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12307909 |
| 56 | Circadian entrainment_Homo sapiens_hsa04713 | 1.11620587 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11359051 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 1.11011323 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10633950 |
| 60 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.09958403 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.06196740 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03317462 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01914434 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01791718 |
| 65 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.94516910 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93340373 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90201963 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89783597 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87344802 |
| 70 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87097937 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.86690413 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.83305722 |
| 73 | GABAergic synapse_Homo sapiens_hsa04727 | 0.81982380 |
| 74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79300292 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79239856 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78806746 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78462960 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78367515 |
| 79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78309028 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.76469701 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75382504 |
| 82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75321403 |
| 83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73071290 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72065476 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.71318165 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69657022 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.69531011 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.68106271 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.68008465 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66566787 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64403103 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63954948 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63722666 |
| 94 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.63651713 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63584666 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63323124 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61242438 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61101128 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60949012 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59788184 |
| 101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59439076 |
| 102 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58121736 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57883716 |
| 104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57793150 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57560948 |
| 106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56374778 |
| 107 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54440833 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53988010 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52574509 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50953063 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.50601551 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49636721 |
| 113 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.49525305 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.48628626 |
| 115 | Malaria_Homo sapiens_hsa05144 | 0.48353884 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47351282 |
| 117 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46880234 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45427827 |
| 119 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45318505 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44941701 |
| 121 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44781593 |
| 122 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44400206 |
| 123 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44235837 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.42675030 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41871195 |
| 126 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34799581 |
| 127 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.33087501 |
| 128 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32545439 |
| 129 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32257413 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.31284286 |
| 131 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30940284 |
| 132 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29002260 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28934324 |
| 134 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.26682613 |
| 135 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.26155490 |
| 136 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25676847 |
| 137 | Leishmaniasis_Homo sapiens_hsa05140 | 0.25411674 |
| 138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25183483 |
| 139 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.24624063 |
| 140 | Tuberculosis_Homo sapiens_hsa05152 | 0.24287676 |
| 141 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23855288 |
| 142 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.23058975 |
| 143 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.22626716 |
| 144 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21626424 |
| 145 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.21165679 |
| 146 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20557576 |
| 147 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20292715 |
| 148 | Influenza A_Homo sapiens_hsa05164 | 0.19379955 |
| 149 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.18271932 |
| 150 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.17713471 |
| 151 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17092063 |
| 152 | Phagosome_Homo sapiens_hsa04145 | 0.16089322 |

